Amd Macular Degeneration

Overview Forums Topics Doctor Questions eHealthpedia
Ask our Community
eHealthpedia Articles
Macular Degeneration Diagnosis
What should you prepare before you see a doctor for macular degeneration? And how do doctors diagnose macular degeneration and AMD?
Macular Degeneration Symptoms
Early symptoms of macular degeneration and symptoms of dry AMD vs. wet AMD may vary. Learn how to identify signs of macular degeneration here.
Macular Degeneration Treatment
Wet and dry age related macular degeneration are treated differently. Learn more about common treatment options for AMD here.
Macular Degeneration
Do you know the difference between wet and dry macular degeneration? And what is macular degeneration in the first place? Macular dengerations basics here.
Macular Degeneration Causes and Risk Factors
Macular degeneration results in serious and irreversible loss of vision. But what causes macular degeneration? And are you at risk of developing dry or wet AMD?
More
Topics
DoanSang
DoanSang / Vision and Eye Disorders
thes415
thes415 / Vision and Eye Disorders
tomroberts
tomroberts / General Q and A
More
Doctor Answers
Srinivas Singaram
Srinivas Singaram / Vision and Eye Disorders
Dr. Nikola Gjuzelov
Dr. Nikola Gjuzelov / Vision and Eye Disorders
More
News
Press Release
The impact of the Comparison of AMD Treatments Trials (CATT) study results published at the end of April 2011 is reflected in changes to both current and anticipated prescribing behavior of Genentech’s Avastin and Lucentis for wet age-related macular de
Why is a $1,575-a-month drug approved and a $7 one isn’t?
The ability of the two treatments, both made by the same company, to stop vision loss is ‘virtually identical’
Impact of CATT Study Findings Evident in Significant Reported Changes in Prescribing of Genentech’s Avastin and ...
EXTON, Pa.--(BUSINESS WIRE)--The impact of the Comparison of AMD Treatments Trials (CATT) study results published at the end of April 2011 is reflected in changes to both current and anticipated prescribing behavior
Eye disease treatment fuels funding dispute
The cheaper drug Avastin shouldn't be an option for treating age-related macular degeneration, the Canadian Council of the Blind says.
ACT Receives Approval from Data and Safety Monitoring Board (DSMB) to Treat Next Patients in Stem Cell Clinical Trials
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company’s two ongoi